READ-MA Multimarker Approach
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Centre Hospitalier Universitaire de Besancon
Overview
READ-MA Multimarker Approach is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
READ-MA Multimarker Approach clinical trials
Explore related
Medical disclaimer. This page summarizes research about READ-MA Multimarker Approach for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.